1. Home
  2. AUNA vs NGNE Comparison

AUNA vs NGNE Comparison

Compare AUNA & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUNA
  • NGNE
  • Stock Information
  • Founded
  • AUNA 1989
  • NGNE 2003
  • Country
  • AUNA Luxembourg
  • NGNE United States
  • Employees
  • AUNA N/A
  • NGNE N/A
  • Industry
  • AUNA
  • NGNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • AUNA
  • NGNE Health Care
  • Exchange
  • AUNA NYSE
  • NGNE Nasdaq
  • Market Cap
  • AUNA 513.7M
  • NGNE 471.1M
  • IPO Year
  • AUNA 2024
  • NGNE N/A
  • Fundamental
  • Price
  • AUNA $6.95
  • NGNE $34.52
  • Analyst Decision
  • AUNA Strong Buy
  • NGNE Strong Buy
  • Analyst Count
  • AUNA 4
  • NGNE 6
  • Target Price
  • AUNA $13.40
  • NGNE $63.80
  • AVG Volume (30 Days)
  • AUNA 25.4K
  • NGNE 353.3K
  • Earning Date
  • AUNA 11-19-2024
  • NGNE 11-15-2024
  • Dividend Yield
  • AUNA N/A
  • NGNE N/A
  • EPS Growth
  • AUNA N/A
  • NGNE N/A
  • EPS
  • AUNA N/A
  • NGNE 0.18
  • Revenue
  • AUNA $1,103,875,022.00
  • NGNE $925,000.00
  • Revenue This Year
  • AUNA $18.29
  • NGNE N/A
  • Revenue Next Year
  • AUNA $10.64
  • NGNE N/A
  • P/E Ratio
  • AUNA N/A
  • NGNE $189.06
  • Revenue Growth
  • AUNA 30.59
  • NGNE N/A
  • 52 Week Low
  • AUNA $6.17
  • NGNE $12.49
  • 52 Week High
  • AUNA $10.85
  • NGNE $74.49
  • Technical
  • Relative Strength Index (RSI)
  • AUNA N/A
  • NGNE 35.74
  • Support Level
  • AUNA N/A
  • NGNE $35.60
  • Resistance Level
  • AUNA N/A
  • NGNE $43.24
  • Average True Range (ATR)
  • AUNA 0.00
  • NGNE 6.02
  • MACD
  • AUNA 0.00
  • NGNE -2.86
  • Stochastic Oscillator
  • AUNA 0.00
  • NGNE 0.00

About AUNA AUNA S A

Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru, Healthcare services in Peru, Healthcare services in Colombia, and Healthcare services in Mexico. Key revenue is generated from Peru.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Share on Social Networks: